Key Takeaways
- In a 358-patient cohort (179 monitored vs. 179 unmonitored controls), Intraoperative Neurophysiological Monitoring (IONM) of the Facial Nerve (FN) raised the 12-month good functional outcome rate (House-Brackmann [HB] I–II) to 88% vs. 73% in controls, and anatomical preservation to 96% vs. 82%.
- FN grade distribution was significantly better in the monitored group at both 2 weeks (χ² = 17.9, P < 0.05) and 12 months (χ² = 22.7, P < 0.05), with both groups showing progressive recovery over time (monitored: χ² = 60.6, P < 0.001; control: χ² = 16.5, P < 0.001).
- Final stimulation threshold at the end of surgery correlated inversely with postoperative FN function: thresholds requiring > 0.5 mA to evoke a response predicted poorer and slower recovery.
- Tumor size stratified outcomes: all 12-month HB grade I patients had tumors < 4 cm, while all HB IV–VI patients had tumors > 4 cm, underscoring the value of monitoring in large vestibular schwannomas where the nerve is thinned and adherent.
Clinical Context
Acoustic neuroma (vestibular schwannoma) is a benign, slow-growing tumor of the cerebellopontine angle, most often unilateral and presenting predominantly in adults and women. FN morbidity is the dominant quality-of-life concern after resection. As microsurgical technique and FN monitoring have matured, the incidence of FN injury has fallen markedly, and IONM is now regarded as essential equipment in modern skull base and cerebellopontine angle tumor surgery—the key to achieving complete tumor removal while preserving facial, cochlear, and even cochlear nerve function.
This analysis compares FN preservation in patients operated under electrophysiological monitoring versus those operated without it, drawing on clinical data from the Department of Neurosurgery, Provincial Hospital Affiliated to Anhui Medical University, a high-volume tertiary surgical center.
Clinical Evidence & Cohort Breakdown
A total of 358 patients undergoing acoustic neuroma resection (May 2016–May 2017) were divided into a monitored group (n = 179; 123 male, 56 female; age 10–68 years, mean 46.4 years) and a control group (n = 179). All procedures were performed by the same surgical team under general anesthesia; neuromuscular blocking agents were withheld to avoid confounding the electromyography (EMG) recordings. FN monitoring, FN function grading, and control-group FN assessment were all performed by the same dedicated electrophysiologist.
| Parameter | Monitored Group (n = 179) | Control Group (n = 179) |
|---|---|---|
| Tumor maximum diameter ≥ 4.0 cm | 88 | 73 |
| Tumor maximum diameter < 4.0 cm | 91 | 106 |
| Gross total resection | 172 | 152 |
| Subtotal resection | 6 | 27 |
| Partial resection | 1 | 0 |
| HB I–II at 2 weeks | 118 | 116 |
| HB I–II at 12 months | 158 | 130 |
| 12-month good functional preservation rate | 88% | 73% |
| 12-month anatomical preservation rate | 96% | 82% |
FN grade distribution (n):
| Grade | Monitored: Preop | Monitored: 2 wk | Monitored: 12 mo | Control: Preop | Control: 2 wk | Control: 12 mo |
|---|---|---|---|---|---|---|
| I | 167 | 18 | 118 | 169 | 20 | 102 |
| II | 8 | 100 | 40 | 6 | 96 | 28 |
| III | 2 | 30 | 15 | 1 | 15 | 17 |
| IV | 0 | 24 | 1 | 2 | 21 | 13 |
| V | 1 | 2 | 0 | 1 | 14 | 4 |
| VI | 1 | 5 | 5 | 0 | 13 | 15 |
Both groups improved over time, but the monitored group showed superior grade distribution at both time points. The delayed recovery pattern (worse at 2 weeks, better at 12 months) is consistent with traction injury, sharp dissection, thermal injury from electrocautery, and injury to nutrient vessels, followed by gradual recovery of supporting cells with neurotrophic and microcirculatory therapy.
Intraoperative IONM Protocol & Technical Pearls
- Anesthesia setup: Withhold neuromuscular blockade to preserve reliable EMG. Confirm absence of Neuromuscular Blockade (NMB) Residual before baseline recording.
- Electrode placement: Place recording Subdermal Needle Electrodes in the orbicularis oculi and orbicularis oris; attach the ground electrode to the arm. Verify impedances and free-running EMG baseline.
- Stimulation parameters: Use a Bipolar Stimulating Probe operated by the surgeon. Set stimulation frequency at 1.1–7.1 Hz and begin at 0.1 mA, increasing gradually until an evoked motor response time-locked to the stimulus is recorded; do not exceed 1 mA.
- Tumor exposure and mapping: After exposure, stimulate the tumor capsule with a slightly higher current. Absence of response excludes nerve within that region and permits resection; a response mandates stepwise reduction of current to localize the FN and avoid early injury.
- Dissection sequence: Perform intratumoral debulking first, then sequential piecemeal resection of the superior and inferior poles, then the internal auditory canal (IAC) tumor, and finally dissection of tumor remnants adherent to the FN.
- Near the IAC and brainstem: Combine spontaneous and triggered EMG, stimulate while cutting, avoid prolonged traction on tumor and vessels, allow intermittent relaxation, favor sharp dissection, avoid thermal injury from electrocautery, and irrigate with cool saline for temperature control. The posterior wall of the IAC must be drilled away to permit total tumor removal.
- Nerve identification (tumor < 4 cm): Distinguish FN, cochlear nerve, and trigeminal nerve under the microscope. For large tumors with lost preoperative hearing, use minimal-current stimulation: no response from the candidate nerve, trigeminal nerve, or FN identifies the cochlear nerve. Alternatively, use Latency (ms): at 0.1 mA, FN latency is 6–8 ms and trigeminal latency is 3–4 ms.
- EMG pattern interpretation: Loss or reduction of burst EMG on direct FN stimulation suggests possible injury; train activity predicts postoperative FN dysfunction; pulse-like artifact may reflect saline irrigation; instrument contact with the nerve produces burst EMG that localizes the FN.
- Closing threshold check: Record the final stimulation threshold. A requirement for > 0.5 mA to evoke a response predicts poorer functional recovery. Proximal stimulation threshold and proximal/distal EMG Amplitude (μV) ratios correlate with immediate postoperative function.
Clinical Implications for Surgeons & IONM Specialists
IONM materially improves both anatomical and functional FN preservation in acoustic neuroma surgery, with the greatest benefit in large tumors where the nerve is thinned, adherent, and nearly fused with the capsule. The monitoring team must not only recognize evoked EMG patterns but also track the surgical field in real time to distinguish traction, thermal, and irrigation artifacts and to communicate nerve location and traction load to the surgeon. Final stimulation threshold is a practical, actionable prognostic marker: thresholds above 0.5 mA should prompt heightened postoperative vigilance and rehabilitation planning. Combined with growing electrophysiologist and surgeon experience, IONM supports safer, more complete resection and better long-term quality of life.
Reference
Liu H, Hu X, Zheng H, Niu C. Significance of intraoperative facial nerve electrophysiological monitoring in acoustic neuroma surgery. Journal of Nanjing Medical University (Natural Sciences). 2019;39(6):922–924. doi:10.7655/NYDXBNS20190627
Medical Disclaimer: This article is provided for educational and informational purposes only and does not constitute medical advice. Clinical decisions regarding Intraoperative Neurophysiological Monitoring and surgical technique should be individualized to each patient and made by qualified healthcare professionals in accordance with institutional protocols and current evidence.